HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Debaki R Howlader Selected Research

dodecyldimethylamine oxide

12/2021Development of a Self-Adjuvanting, Cross-Protective, Stable Intranasal Recombinant Vaccine for Shigellosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Debaki R Howlader Research Topics

Disease

2Infections
01/2020 - 01/2018
1Type I Syndactyly
12/2021
1Bacillary Dysentery (Shigellosis)
12/2021
1Pneumonia (Pneumonitis)
01/2020
1Pseudomonas Infections
01/2020
1Typhoid Fever (Typhoid)
01/2018

Drug/Important Bio-Agent (IBA)

3VaccinesIBA
12/2021 - 01/2018
1Detergents (Detergent)IBA
12/2021
1Synthetic Vaccines (Recombinant Vaccines)IBA
12/2021
1dodecyldimethylamine oxideIBA
12/2021
1Subunit VaccinesIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Combined VaccinesIBA
01/2018